Caredx Inc (CDNA)

Feb 21, 2025, 9:43 AM EST - 1 day ago

Johnson Fistel has Commenced an Investigation on Behalf of CareDx, Inc. Shareholders

Feb 20, 2025, 7:05 AM EST - 2 days ago

CareDx Announces Study Showing AlloSeq cfDNA Highly Accurate in Detecting Rejection in Organ Transplant Patients

Feb 13, 2025, 7:05 AM EST - 9 days ago

CareDx Announces Presentation of Data at 2025 Tandem Meetings Demonstrating Strong Performance of AlloHeme in Early Relapse Detection for Hematologic Malignancies

Feb 11, 2025, 7:05 AM EST - 11 days ago

CareDx to Report Fourth Quarter and Full Year 2024 Financial Results

Feb 10, 2025, 2:08 PM EST - 12 days ago

Final Trades: NRG Energy, MP Materials, CareDx and Applovin

APP MP NRG

Jan 13, 2025, 7:00 AM EST - 5 weeks ago

CareDx Announces Preliminary Fourth Quarter and Full Year 2024 Results

Dec 25, 2024, 1:23 AM EST - 2 months ago

CareDx: Top Of My Shopping List For 2025

Dec 18, 2024, 7:05 AM EST - 2 months ago

CareDx to Participate in the 43rd Annual J.P. Morgan Healthcare Conference

Dec 11, 2024, 7:00 AM EST - 2 months ago

TCBP Partners with CareDx to Support ACHIEVE Clinical Trial Using AlloCell for Pharmacokinetic Monitoring of Allogeneic Cell Therapy

TCBP

Dec 11, 2024, 7:00 AM EST - 2 months ago

CareDx Partners with TC BioPharm to Support ACHIEVE Clinical Trial Using AlloCell for Pharmacokinetic Monitoring of Allogeneic Cell Therapy

Nov 12, 2024, 7:05 AM EST - 3 months ago

CareDx to Participate in Upcoming Investor Conferences

Nov 4, 2024, 10:05 PM EST - 3 months ago

CareDx, Inc (CDNA) Q3 2024 Earnings Call Transcript

Nov 4, 2024, 4:05 PM EST - 3 months ago

CareDx Reports Third Quarter 2024 Results and Raises Revenue Guidance

Oct 25, 2024, 5:15 PM EDT - 4 months ago

CAREDX INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of CareDx, Inc. - CDNA

Oct 23, 2024, 7:00 AM EDT - 4 months ago

CareDx and Dovetail Genomics Announce Strategic Partnership to Drive Next Wave of Innovation in Transplant Matching with Cutting-Edge Hi-C Technology

Oct 21, 2024, 7:00 AM EDT - 4 months ago

CareDx Showcases Latest Advancements Across its HLA Typing Solutions at Annual American Society for Histocompatibility and Immunogenetics Meeting

Oct 15, 2024, 8:26 AM EDT - 4 months ago

CareDx, JD.com And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

JD

Oct 15, 2024, 6:00 AM EDT - 4 months ago

CareDx Reports Preliminary Financial Results for Third Quarter 2024

Oct 11, 2024, 4:30 PM EDT - 4 months ago

CareDx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Oct 9, 2024, 7:05 AM EDT - 4 months ago

CareDx Appoints Jing Huang Chief Data and AI Officer

Oct 8, 2024, 4:05 PM EDT - 4 months ago

CareDx to Host Investor Day on October 15, 2024

Oct 8, 2024, 6:05 AM EDT - 4 months ago

CareDx Announces Closure of DOJ Investigation with No Finding of Wrongdoing

Oct 2, 2024, 12:06 PM EDT - 5 months ago

CareDx Inc (CDNA) Trading 6.16% Higher on Oct 2

Sep 29, 2024, 7:32 PM EDT - 5 months ago

CareDx Resolves Key Issues: Poised For Growth In Transplant Diagnostics

Sep 13, 2024, 8:33 PM EDT - 5 months ago

CareDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Sep 12, 2024, 7:01 AM EDT - 5 months ago

CareDx Appoints Keith Kennedy Chief Operating Officer and Jessica Meng Chief Commercial Officer

Aug 16, 2024, 2:10 PM EDT - 6 months ago

CareDx Announces Transplant Community Secures Win Reaffirming Longstanding Medicare Coverage for AlloSure and AlloMap Testing

Jul 31, 2024, 8:03 PM EDT - 7 months ago

CareDx, Inc. (CDNA) Q2 2024 Earnings Call Transcript

Jul 31, 2024, 4:05 PM EDT - 7 months ago

CareDx Reports Second Quarter 2024 Results and Increases Revenue Guidance

Jul 16, 2024, 7:05 AM EDT - 7 months ago

CareDx to Report Second Quarter 2024 Financial Results

Jun 3, 2024, 7:05 AM EDT - 9 months ago

Landmark Independent Publication in Nature Medicine Validates CareDx AlloView AI-Enabled Risk Prediction Model and Demonstrates AlloSure Kidney Detects Subclinical Rejection in Stable Patients

May 30, 2024, 7:05 AM EDT - 9 months ago

AI Integration and Real-World Utility of CareDx Portfolio Highlighted in New Data at the 2024 American Transplant Congress

May 29, 2024, 8:05 AM EDT - 9 months ago

CareDx Reiterates Position that it Does Not Infringe the ‘544 Patent, Injunction Motion is Irrelevant

May 16, 2024, 4:05 PM EDT - 10 months ago

Landmark Study Shows CareDx's HeartCare Outperforms dd-cfDNA Alone in Identifying Rejection and Patients Experienced Excellent Outcomes with Fewer Biopsies

May 9, 2024, 10:42 PM EDT - 10 months ago

CareDx, Inc. (CDNA) Q1 2024 Earnings Call Transcript

May 9, 2024, 4:05 PM EDT - 10 months ago

CareDx Reports First Quarter 2024 Results

May 3, 2024, 4:10 PM EDT - 10 months ago

CareDx Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

Apr 29, 2024, 4:05 PM EDT - 10 months ago

CareDx to Report First Quarter 2024 Financial Results

Apr 19, 2024, 4:05 PM EDT - 11 months ago

CareDx Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

Apr 16, 2024, 4:02 PM EDT - 11 months ago

CareDx Appoints John W. Hanna as its New President and Chief Executive Officer

Apr 9, 2024, 7:00 AM EDT - 11 months ago

CareDx and Collaborators Present Latest Cardiothoracic Advancements at the 2024 International Society for Heart and Lung Transplantation Meeting

Mar 11, 2024, 4:10 PM EDT - 1 year ago

CareDx Appoints Bryan Riggsbee to Its Board of Directors

Feb 28, 2024, 10:22 PM EST - 1 year ago

CareDx, Inc. (CDNA) Q4 2023 Earnings Call Transcript

Feb 28, 2024, 4:05 PM EST - 1 year ago

CareDx Announces Fourth Quarter and Full Year 2023 Financial Results

Feb 27, 2024, 4:05 PM EST - 1 year ago

CareDx to Participate in the Raymond James & Associates' 45th Annual Institutional Investors Conference

Feb 21, 2024, 4:05 PM EST - 1 year ago

CareDx to Report Fourth Quarter and Full Year 2023 Financial Results

Feb 21, 2024, 7:00 AM EST - 1 year ago

CareDx Showcases Digital Solutions and Pipeline in Cellular Transplant and Therapy Monitoring at the 2024 Tandem Meetings

Jan 26, 2024, 9:45 PM EST - 1 year ago

CareDx Issues Statement in Patent Infringement Case

NTRA